Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
19566-9 Methylenedioxyamphetamine PrThr Urine Pt Ord Confirm   ACTIVE Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19566-9   Confirm     Both       0 MDA Ur Ql Cfm           Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; MDA; Methylenedioxymethamphetamine metabolite; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19567-7 Methylenedioxyamphetamine cutoff MCnc Urine Pt Qn Screen   ACTIVE Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19567-7   Screen     Observation       0 MDA CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MDA; Methylenedioxymethamphetamine metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.44 1.0l               ng/mL       0
19568-5 Methylenedioxymethamphetamine PrThr Urine Pt Ord Screen   ACTIVE Methylenedioxymethamphetamine [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19568-5   Screen     Both       0 MDMA Ur Ql Scn           Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19569-3 Methylenedioxymethamphetamine PrThr Urine Pt Ord Confirm   ACTIVE Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19569-3   Confirm     Both       0 MDMA Ur Ql Cfm           Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; GCMS; Illicit; LC/MS/MS; MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
1957-0 Beta-N-acetylhexosaminidase.B CCnc Ser/Plas Pt Qn     ACTIVE Beta-N-acetylhexosaminidase.B [Enzymatic activity/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/h/mL             CHEM   1957-0         Both       0 Hexosaminidase B SerPl-cCnc       Y   B; B-NAH; Catalytic Concentration; Chemistry; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Hexosaminidase B; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sandhoff disease; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tay Sachs Disease 2.73 1               nmol/h/mL     Updated System from Ser to Ser/Plas since this test can be performed on serum or plasma. 0
19570-1 Methylenedioxymethamphetamine MCnc Urine Pt Qn     ACTIVE Methylenedioxymethamphetamine [Mass/volume] in Urine   MIN DefinitionDescription     ng/mL             DRUG/TOX   19570-1         Both       0 MDMA Ur-mCnc       Y   Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; Level; Mass concentration; MDMA; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0l               ng/mL       0
19571-9 Methylenedioxymethamphetamine cutoff MCnc Urine Pt Qn Screen   ACTIVE Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19571-9   Screen     Observation       0 MDMA CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Ecstasy; Level; Mass concentration; MDMA; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.73 1.0l               ng/mL       0
19572-7 Methylenedioxymethamphetamine cutoff MCnc Urine Pt Qn Confirm   ACTIVE Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19572-7   Confirm     Observation       0 MDMA CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; Ecstasy; GCMS; LC/MS/MS; Level; Mass concentration; MDMA; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
19573-5 MethylePHEDrine PrThr Urine Pt Ord Screen   ACTIVE MethylePHEDrine [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19573-5   Screen     Both       0 Me-ePHEDrine Ur Ql Scn           Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ivilco; Me-ePHEDrine; Ordinal; Pholcomed; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tossamine plus; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19575-0 MethylePHEDrine cutoff MCnc Urine Pt Qn Screen   ACTIVE MethylePHEDrine cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19575-0   Screen     Observation       0 Me-ePHEDrine CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Ivilco; Level; Mass concentration; Me-ePHEDrine; Pholcomed; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Tossamine plus; UA; UR; Urn 2.44 1.0l               ng/mL       0
19576-8 MethylePHEDrine cutoff MCnc Urine Pt Qn Confirm   ACTIVE MethylePHEDrine cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19576-8   Confirm     Observation       0 Me-ePHEDrine CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Ivilco; LC/MS/MS; Level; Mass concentration; Me-ePHEDrine; Pholcomed; Point in time; QNT; Quan; Quant; Quantitative; Random; Tossamine plus; UA; UR; Urn 2.44 1.0l               ng/mL       0
19577-6 Methylphenidate PrThr Urine Pt Ord Screen   ACTIVE Methylphenidate [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19577-6   Screen     Both       0 Me-phenidate Ur Ql Scn           Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Me-phenidate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Ritalin; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19578-4 Methylphenidate PrThr Urine Pt Ord Confirm   ACTIVE Methylphenidate [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19578-4   Confirm     Both       0 Me-phenidate Ur Ql Cfm           Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Me-phenidate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Ritalin; Screen; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19579-2 Methylphenidate cutoff MCnc Urine Pt Qn Screen   ACTIVE Methylphenidate cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19579-2   Screen     Observation       0 Me-phenidate CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Me-phenidate; Point in time; QNT; Quan; Quant; Quantitative; Random; Ritalin; Scn; Scr; Scrn; UA; UR; Urn 2.44 1.0l               ng/mL       0
1958-8 Beta-N-acetylhexosaminidase.I CCnc Ser Pt Qn     ACTIVE Beta-N-acetylhexosaminidase.I [Enzymatic activity/volume] in Serum   MIN DefinitionDescription     nmol/h/mL             CHEM   1958-8         Both       0 Hexosaminidase I Ser-cCnc       Y   B; B-NAH; Catalytic Concentration; Chemistry; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Hexosaminidase I; Point in time; QNT; Quan; Quant; Quantitative; Random; Sandhoff disease; Serum; SR; Tay Sachs Disease 2.42 1               nmol/h/mL       0
19580-0 Methylphenidate cutoff MCnc Urine Pt Qn Confirm   ACTIVE Methylphenidate cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19580-0   Confirm     Observation       0 Me-phenidate CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Me-phenidate; Point in time; QNT; Quan; Quant; Quantitative; Random; Ritalin; UA; UR; Urn 2.44 1.0l               ng/mL       0
19581-8 Methyprylon PrThr Urine Pt Ord Screen   ACTIVE Methyprylon [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19581-8   Screen     Both       0 Methyprylon Ur Ql Scn           DRUG/TOXICOLOGY; Drugs; Methprylon; Noludar; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19583-4 Methyprylon cutoff MCnc Urine Pt Qn Screen   ACTIVE Methyprylon cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19583-4   Screen     Observation       0 Methyprylon CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Methprylon; Noludar; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.44 1.0l               ng/mL       0
19584-2 Methyprylon cutoff MCnc Urine Pt Qn Confirm   ACTIVE Methyprylon cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19584-2   Confirm     Observation       0 Methyprylon CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Methprylon; Noludar; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
19585-9 Midazolam PrThr Urine Pt Ord Screen   ACTIVE Midazolam [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19585-9   Screen     Both       0 Midazolam Ur Ql Scn           DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn; Versed 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19586-7 Midazolam PrThr Urine Pt Ord Confirm   ACTIVE Midazolam [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19586-7   Confirm     Both       0 Midazolam Ur Ql Cfm           Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Versed 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19588-3 Midazolam MCnc Urine Pt Qn     ACTIVE Midazolam [Mass/volume] in Urine   MIN DefinitionDescription     ug/mL             DRUG/TOX   19588-3         Both       0 Midazolam Ur-mCnc       Y   DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Versed 2.73 1.0l               ug/mL       0
19589-1 Midazolam cutoff MCnc Urine Pt Qn Screen   ACTIVE Midazolam cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19589-1   Screen     Observation       0 Midazolam CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn; Versed 2.44 1.0l               ng/mL       0
1959-6 Bicarbonate SCnc Bld Pt Qn     ACTIVE Bicarbonate [Moles/volume] in Blood   MIN DefinitionDescription     mmol/L             CHEM   1959-6         Both       0 HCO3 Bld-sCnc       Y   BIC; bicar; Bicarb; Blood; Chemistry; HCO3; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration; WB; Whole blood 2.73 1               mmol/L       0
19590-9 Midazolam cutoff MCnc Urine Pt Qn Confirm   ACTIVE Midazolam cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19590-9   Confirm     Observation       0 Midazolam CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Versed 2.73 1.0l               ng/mL       0
104,672 results found